Connect with us

Cannabis

Pharmacists ready to play key role in improving healthcare and ending hallway medicine

Published

on

Reading Time: 3 minutes

 

The Ontario Pharmacists Association (OPA) welcomes the second report issued today by Premier Ford’s Council on Improving Healthcare and Ending Hallway Medicine and looks forward to being part of the solution to improving the design and delivery of services in Ontario so that patients receive the right care, at the right time and in the right setting.

The report provides 10 policy recommendations and associated actions that focus on four themes:  integration, innovation, efficiency and alignment, and capacity – all strategically linked to achieve the objectives of the internationally recognized quadruple aim of healthcare:

  • Improving the patient and caregiver experience;
  • Improving the health of populations;
  • Reducing the per capita cost of healthcare while striving for value for money invested; and,
  • Improving the provider experience.

“A number of the recommendations from the report support the government’s commitment in the 2019 budget to expand pharmacists’ scope of practice, including their authority to assess and, when necessary, treat patients for common ailments,” says Jen Baker, Chair of the Board for OPA. “We’re eager to continue working alongside our healthcare partners to ensure patients, whether in the community, long-term care home or hospital, have access to services within a fully integrated, multi-disciplinary healthcare system.”

OPA supports many of the proposed action items of the report and highlights the following three areas that reflect the expanded role of pharmacists in Ontario:

  • “Ensure providers are well-supported and maximizing their permitted scope of practice.” (p.36) – OPA is committed to collaborating with the Ontario College of Pharmacists, the Ministry of Health and Ministry of Long-Term Care to ensure that pharmacists are well-equipped to deliver the care their patients need;

  • “Work with primary care providers to ensure they have information sharing and referral tools to link with all appropriate community providers, enabling seamless transitions for patients, with continued involvement by primary care.” (p.22) and “Enabling health data to be shared between providers so that patients receive better-integrated care, and so that providers will have a more complete picture of their patients’ health status.” (p.20) – Pharmacists are the most accessible healthcare providers in the community with more than 4,400 pharmacies across Ontario, many of which are open late and even 24/7. The information community pharmacists document in their provision of care for their patients is invaluable to other healthcare professionals. Pharmacy management systems are beginning to get integrated with physician-based electronic medical records via clinical viewers to enable multi-directional and multi-disciplinary sharing of information so that patients can take comfort in knowing that providers within their circle of care are communicating with each other. Ontario’s pharmacists fully support making patient data accessible so that healthcare providers have a more fulsome picture of a patient’s health and can ensure the most appropriate care is provided; and 

  • “Support health sector leaders and ensure they have the skills and tools to lead by example and support the sector through a fundamental culture change.” (p.38) – OPA provides members of the pharmacy community with professional development to ensure the pharmacy community is prepared for healthcare transformation, including accredited programs relating to cannabis, immunization and injections and treating common ailments.

“The changes we are seeing in healthcare right now are more than just a transformation in structure. These action items will put patients at the centre of their care and will ensure they are supported inter-professionally by healthcare professionals within their circle of care, which includes their pharmacist,” says Baker. “More than ever, Ontario’spharmacists are ready and want to provide more care. Patients and government need to rethink pharmacy and recognize the level of service and expertise pharmacists are trained to provide to help keep Ontarians healthy.”

Pharmacists continue to demonstrate their integral role across the healthcare continuum. Just this year, pharmacists administered more than 1.2 million flu vaccines to patients across Ontario. In addition, pharmacists are helping to protect communities by providing vaccines for 13 diseases including hepatitis A and B, HPV, varicella (chicken pox), meningococcal disease and pneumococcal disease.

“Pharmacists are trained healthcare professionals who can help. Not only can we keep patients out of emergency departments, but we can keep patients and their whole communities protected and healthy,” says Bill Wilson, OPA’s interim CEO. “Ontario pharmacists are ready to contribute to the Ford government’s new vision of a long-term, modern, sustainable, efficient and integrated healthcare system focused on the patient.”

 

SOURCE Ontario Pharmacists Association

Cannabis

Medicine Man Technologies to Present at Benzinga Cannabis Capital Conference

Published

on

Photo source: uchealth.org

On the first anniversary of Canadian cannabis legalization, “Legalization 2.0” or “Cannabis 2.0” will allow popular cannabis derivatives like edibles, infused beverages, and vapes to legally be bought and sold nationwide. Demand for these products is incredibly high, and most analysts believe that cannabis derivatives will allow companies to deliver on ambitious revenue projections for the still-growing pot industry. Because this market is so important, companies that are prepared to capitalize on cannabis-derived consumables—like BevCanna Enterprises Inc. (CSE:BEV) (OTCPK:BVNNF), MediPharm Labs Corp. (TSX:LABS) (OTCQX:MEDIF), Cronos Group (TSX:CRON) (NASDAQ:CRON), Valens GroWorks (TSXV:VGW) (OTCQX:VGWCF)and IAnthus Capital Holdings, Inc. (CSE:IAN) (OTCQX:ITHUF)—are likely to ride the new wave of legalization and become the major industry players of tomorrow.

According to a comprehensive report from Deloitte called Nurturing New Growth: Canada Gets Ready for Cannabis 2.0, the Canadian market for edibles and alternative cannabis products will be worth $2.7 billion annually. $1.6 billion of that will be from edibles alone, and $529 million will be from beverages.

BevCanna is Best Positioned to Deliver Cannabis Beverages

BevCanna Enterprises Inc. (CSE:BEV) (OTCPK:BVNNF) understands better than perhaps any other company what kind of opportunity “legalization 2.0” provides for the cannabis industry. With its goal to become the global leader in cannabis-infused drinks, BevCanna has done an exceptionally good job of preparing itself for the new consumables market.

The last few months have seen a bevvy of activity for BevCanna. The company recently completed independent lab testing on its proprietary powder ingredient, Deeper Green, which allows for a full range of cannabinoid inputs, including THC, CBD, full-spectrum extracts and hemp-based CBD. The company also has an exclusive supply agreement with Nextleaf Solutions to employ its water-soluble cannabinoids for development and manufacturing, as well as a research license allowing BevCanna to look into the stability and homogeneity of water-soluble cannabinoid infusions in water-based beverages.

All this means that BevCanna has the technology and the permits in place to deliver cannabis drinks that are both high-quality and reliable. Accomplishing just one of these tasks is a monumental achievement, but having both in place in time for “legalization 2.0” puts the company in an industry-leading position.

BevCanna Enterprises Inc. (BEV-BVNNF)‘s two announced products lines, Anarchist Mountain Beverages and Grüv Beverages provide the company with brands that are broadly appealing for consumers interested in cannabis drinks. Anarchist Mountain is a line of THC-dominant sparkling spring water beverages with botanical flavor profiles inspired by the Pacific Northwest. Grüv is a wide range of easy-drinking cannabis-infused iced tea drinks with a balanced CBD and THC profile. Additionally, BevCanna is in “the final development stage for a third product line that will be the catalyst for the launch of the company’s water-soluble powder beverage line in California,” according to its corporate update.

At the beginning of October, the company entered into a definitive agreement with Higharchy Ventures to manufacture and launch a portfolio of cannabis-infused beverage brands for the Canadian market. The brands will be distributed throughout Canada via Higharchy’s retail cannabis network, and as part of the rollout, BevCanna plans to establish a retail education and training program. This program will focus on educating store staff on the infused beverage category and responsible consumption.

Also, in its recent corporate updateBevCanna Enterprises Inc. (CSE:BEV) (OTC:BVNNF) laid out its objects for the next six months, which mostly center on forming relationships with LPs looking to enter the infused products market in Canada, as well as forming strategic relationships with companies and brands that offer complimentary products.

Already, 11% of Canadians consume cannabis products like edibles and infused beverages, and according to the Deloitte report, another 13% are expected to start buying them when they become legal. With nearly one in four citizens in Canada currently or likely to consume cannabis edibles and alternative products, Deloitte says that “legalizing these products should clearly create valuable new growth opportunities for Canada’s cannabis sector.”

Other Companies That Can Deliver Products to a Hungry Market

BevCanna Enterprises Inc. (BEV-BVNNF) won’t be the only company to benefit from “Legalization 2.0.” Many of its contemporaries are working hard to establish themselves in the newly legal markets.

In preparing for the new legislation governing cannabis derivatives, MediPharm Labs Corp. (TSX:LABS) (OTCQX:MEDIF) VP of investor relations & communications Laura Lepore says that her company is building “the largest vape pen platform in all of Canada.” A big part of that is the company’s white label agreement with Ace Valley, which in signed in June, to launch a premium line of approximately 2 million Ace Valley-branded cannabis extract-based vape pens to Canadian consumers.

MediPharms has also signed a manufacturing agreement with Cronos Group (TSX:CRON) (NASDAQ:CRON), which will see the company produce high-quality cannabis concentrate filled vapes for Cronos Group’s COVE brand. Vape pens have been called the key to Cronos Group’s success, and its Cronos Device Labs in Israel—which is focused on developing vape products for cannabis applications—could just be the driving force to make Cronos a leader in the vape pen category.

Not to be outdone, Valens GroWorks (TSXV:VGW) (OTCQX:VGWCF) is making sure it remains the go-to cannabis extraction company as legalization 2.0 impacts the industry. Valens already lists major market players such as Canopy Growth, HEXO, and The Green Organic Dutchman among its clientele, and to make sure that it can meet the demand for cannabis extracts once edibles can be produced and sold, it has increased its annual extraction capacity to 425,000 kgs of dried cannabis and hemp biomass.

Like MediPharm and BevCanna Enterprises Inc. (BEV-BVNNF)Valens also entered a white-label contract that will see it produce a minimum of 2.5 million THC and CBD infused beverages over five years for Iconic Brewing.

While those companies prepare to capture the burgeoning cannabis consumables market in CanadaIAnthus Capital Holdings, Inc. (CSE:IAN) (OTCQX:ITHUF) hopes to take a similar approach in the US market wherever it can. According to its Q2 financial earnings report, the company can sell extracts such as vape cartridges, edibles, waxes, and tinctures in the state of ArizonaIAnthus also increased its production by 30 percent in Q2 over the previous quarter and is planning to use this added capacity to fuel rollouts in New YorkNew Jersey, and Massachusetts.

The Growing Market for Cannabis Consumables and Extracts

survey conducted by Ernst & Young found that once cannabis products like gummies and face creams become available, they will attract as many as 3 million new Canadian consumers to the market.

Outside of Canada, the market for cannabis consumables is growing exponentially. According to Zion Research, the global market for cannabis beverages is going to grow in value from 1.6 billion to $4.5 billion in 2025, at a CAGR of approximately 15%. Meanwhile, Arcview projects that the edibles market could be worth over $4.1 billion in just Canada and the United States by 2022.

BevCanna Enterprises Inc. (BEV-BVNNF) has made sure it can capitalize on the markets created by “Legalization 2.0.” It will do this through its multiple agreements to test, manufacture, and supply pot beverages, both for its own brands and for clients.

It will be joined in the new markets by MediPharm Labs Corp. and its partner Cronos Group, as well as Valens GroWorks 

 

SOURCE Potstocknews.com

Continue Reading

Cannabis

Sunniva Announces Amendment Of Performance Warrants

Published

on

 

Sunniva Inc. (“Sunniva” or the “Company”) (CSE:SNN) (OTCQB:SNNVF), a North American provider of cannabis products and services, announces that it is amending the terms of the 718,249 performance warrants (the “Performance Warrants”) issued in conjunction with the acquisition of LTYR Logistics, LLC (“LTYR”) on December 31, 2018. The Performance Warrants are convertible into 718,249 common shares of the Company (“Performance Shares”) upon the satisfaction of certain operational milestones (the “Milestones”).

The Performance Warrants will be amended by replacing the original Milestone of opening a distribution business at the Company’s facility in Long Beach, California with the opening of a distribution business at the Company’s facility in Coachella, California. Upon amendment of the Performance Warrants, the Milestones will be satisfied and the Company will convert the Performance Warrants into Performance Shares.

The amendment of the 239,491 Performance Warrants held by Mr. Kevin Wilkerson, President of the Company and the former CEO of LTYR, is considered to be a “related party transaction” within the meaning of Multilateral Instrument 61-101 Protection of Minority Security Holders in Special Transactions (“MI 61-101”). The Company is relying on the exemptions from the formal valuation and minority shareholder approval requirements of MI 61-101, as neither the fair market value of the subject matter of, nor the fair market value of the consideration from, the amendment of the Performance Warrants held by Mr. Wilkerson, exceeds 25% of the Company’s market capitalization.

For more information please visit: www.sunniva.com.

To be added to the Sunniva email distribution list please register at www.sunniva.com/email-alerts.

The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.

 

SOURCE Sunniva Inc.

Continue Reading

Cannabis

Employers still face cannabis-related challenges, a year after legalization

Published

on

Photo source: crainsdetroit.com

 

Employers are still facing challenges related to cannabis in the workplace a year into legalization, finds a new survey by the Canadian Federation of Independent Business (CFIB). In fact, nearly six in 10 business owners rank their provincial government’s efforts to educate them as poor or very poor.

“Cannabis legalization posed some major new challenges for employers, especially in industries where the safety of employees or customers is a concern. We warned governments in the lead-up to legalization that their education efforts were severely lacking. A year in, and as new products become available, it doesn’t look like it’s gotten much better,” said CFIB president Dan Kelly. “We’re finding that provincial governments still have not done a great job of informing employers of their responsibilities, relevant rules and regulations, as well as the resources available to them.”

Only 8 per cent of surveyed businesses had experienced a cannabis-related incident in the workplace since October 17, 2018, but that number rises to 22 per cent for businesses with 100 to 499 employees, according to the preliminary data. Businesses in hospitality were most likely to report having had an incident (16 per cent).

The survey also found that:

  • Only a quarter of businesses list their provincial government as a primary source of information related to cannabis in the workplace.
  • 32 per cent listed CFIB as a primary source of information, while 48 per cent did not have a primary source of information.
  • 59 per cent of those who had a primary source of information felt better equipped to deal with cannabis in the workplace.
  • 34 per cent of businesses do not have a drug and alcohol policy in place.

“Many small businesses don’t have an HR department or legal experts on staff so they need help and resources, but too often, their needs are treated as an afterthought when governments rush to introduce major new legislation,” added Kelly. “I advise any business owners that are looking for information to visit cfib.ca/cannabis for tools and resources, including a free workplace drug and alcohol policy template.”

 

SOURCE Canadian Federation of Independent Business

Continue Reading

Trending Online

Grassnews is a news publishing website which digests / hand picks the latest news about the cannabis industry, and serves them to you daily.

Contact us: pressroom@grassnews.net

© Grassnews.net 2019 - part of PICANTE Media. All rights reserved. Registered in Romania under Proshirt SRL, Company number: 2134306, EU VAT ID: RO21343605. Office address: Blvd. 1 Decembrie 1918 nr.5, Targu Mures, Romania